Safety of Hypericum extract in mildly to moderately depressed outpatients: A review based on data from three randomized, placebo-controlled trials
- 15 October 2004
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 82 (2) , 303-307
- https://doi.org/10.1016/j.jad.2003.12.017
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy of St. John’s Wort Extract WS 5570 in Major Depression: A Double-Blind, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2002
- Efficacy and Tolerability of Hypericum Extract WS 5572 versus Placebo in Mildly to Moderately Depressed Patients - A randomized double-blind multicenter clinical trial -Pharmacopsychiatry, 2001
- St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4Clinical Pharmacology & Therapeutics, 2000
- Second thoughts about safety of St John's wortThe Lancet, 1999
- St. John's Wort for DepressionJournal of Nervous & Mental Disease, 1999
- Adverse effects profile of the herbal antidepressant St. John's wort ( Hypericum perforatum L.)European Journal of Clinical Pharmacology, 1998
- St John's Wort (‘Hypericum perforatum’) - a Herbal AntidepressantCurrent Medical Research and Opinion, 1998
- Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in HumansPharmacopsychiatry, 1997
- Reversible Erhöhung der Photosensitivität im UV-B-Bereich durch Johanniskrautextrakt- PräparateDie Dermatologie, 1997
- St John's wort for depression--an overview and meta-analysis of randomised clinical trialsBMJ, 1996